1	Unilab	_	NNP	_	_	8	SBJ	_	_
2	Corp.	_	NNP	_	_	1	POSTHON	_	_
3	,	_	,	_	_	1	P	_	_
4	Norcross	_	NNP	_	_	1	APPO	_	_
5	,	_	,	_	_	4	P	_	_
6	Ga.	_	NNP	_	_	4	APPO	_	_
7	,	_	,	_	_	1	P	_	_
8	said	_	VBD	_	_	0	ROOT	_	_
9	it	_	PRP	_	_	10	SBJ	_	_
10	acquired	_	VBD	_	_	8	OBJ	_	_
11	the	_	DT	_	_	13	NMOD	_	_
12	clinical	_	JJ	_	_	13	NMOD	_	_
13	laboratories	_	NNS	_	_	10	OBJ	_	_
14	of	_	IN	_	_	13	NMOD	_	_
15	closely	_	RB	_	_	16	AMOD	_	_
16	held	_	VBN	_	_	19	NMOD	_	_
17	Central	_	NNP	_	_	19	NAME	_	_
18	Diagnostic	_	NNP	_	_	19	NAME	_	_
19	Laboratory	_	NNP	_	_	14	PMOD	_	_
20	Inc.	_	NNP	_	_	19	POSTHON	_	_
21	in	_	IN	_	_	10	LOC	_	_
22	a	_	DT	_	_	23	NMOD	_	_
23	cash	_	NN	_	_	21	PMOD	_	_
24	and	_	CC	_	_	23	COORD	_	_
25	securities	_	NNS	_	_	26	NMOD	_	_
26	transaction	_	NN	_	_	24	CONJ	_	_
27	valued	_	VBN	_	_	23	APPO	_	_
28	at	_	IN	_	_	27	ADV	_	_
29	$	_	$	_	_	28	PMOD	_	_
30	85	_	CD	_	_	29	DEP	_	_
31	million	_	CD	_	_	29	DEP	_	_
32	.	_	.	_	_	8	P	_	_

1	Unilab	_	NNP	_	_	2	SBJ	_	_
2	said	_	VBD	_	_	0	ROOT	_	_
3	its	_	PRP$	_	_	8	NMOD	_	_
4	wholly	_	RB	_	_	5	AMOD	_	_
5	owned	_	VBN	_	_	8	NMOD	_	_
6	MetWest	_	NNP	_	_	8	NMOD	_	_
7	Inc.	_	NNP	_	_	8	NMOD	_	_
8	unit	_	NN	_	_	9	SBJ	_	_
9	paid	_	VBD	_	_	2	OBJ	_	_
10	$	_	$	_	_	9	OBJ	_	_
11	25	_	CD	_	_	10	DEP	_	_
12	million	_	CD	_	_	10	DEP	_	_
13	in	_	IN	_	_	10	NMOD	_	_
14	cash	_	NN	_	_	13	PMOD	_	_
15	,	_	,	_	_	9	P	_	_
16	provided	_	VBN	_	_	9	VC	_	_
17	$	_	$	_	_	16	OBJ	_	_
18	30	_	CD	_	_	17	DEP	_	_
19	million	_	CD	_	_	17	DEP	_	_
20	in	_	IN	_	_	17	NMOD	_	_
21	notes	_	NNS	_	_	20	PMOD	_	_
22	and	_	CC	_	_	17	COORD	_	_
23	$	_	$	_	_	22	CONJ	_	_
24	30	_	CD	_	_	23	DEP	_	_
25	million	_	CD	_	_	23	DEP	_	_
26	in	_	IN	_	_	23	NMOD	_	_
27	preferred	_	VBN	_	_	28	NMOD	_	_
28	stock	_	NN	_	_	26	PMOD	_	_
29	to	_	TO	_	_	9	PRP	_	_
30	acquire	_	VB	_	_	29	IM	_	_
31	Central	_	NNP	_	_	33	NMOD	_	_
32	's	_	POS	_	_	31	SUFFIX	_	_
33	labs	_	NNS	_	_	30	OBJ	_	_
34	in	_	IN	_	_	33	LOC	_	_
35	the	_	DT	_	_	37	NMOD	_	_
36	Western	_	NNP	_	_	37	NAME	_	_
37	U.S.	_	NNP	_	_	34	PMOD	_	_
38	.	_	.	_	_	2	P	_	_

1	Unilab	_	NNP	_	_	9	SBJ	_	_
2	,	_	,	_	_	1	P	_	_
3	which	_	WDT	_	_	4	SBJ	_	_
4	provides	_	VBZ	_	_	1	NMOD	_	_
5	clinical	_	JJ	_	_	7	NMOD	_	_
6	laboratory	_	NN	_	_	7	NMOD	_	_
7	services	_	NNS	_	_	4	OBJ	_	_
8	,	_	,	_	_	1	P	_	_
9	competed	_	VBD	_	_	0	ROOT	_	_
10	with	_	IN	_	_	9	ADV	_	_
11	Central	_	NNP	_	_	10	PMOD	_	_
12	,	_	,	_	_	11	P	_	_
13	based	_	VBN	_	_	11	APPO	_	_
14	in	_	IN	_	_	13	LOC	_	_
15	Tarzana	_	NNP	_	_	14	PMOD	_	_
16	,	_	,	_	_	15	P	_	_
17	Calif.	_	NNP	_	_	15	APPO	_	_
18	,	_	,	_	_	9	P	_	_
19	in	_	IN	_	_	9	LOC	_	_
20	a	_	DT	_	_	21	NMOD	_	_
21	number	_	NN	_	_	19	PMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	areas	_	NNS	_	_	22	PMOD	_	_
24	.	_	.	_	_	9	P	_	_

1	Beyond	_	IN	_	_	8	ADV	_	_
2	removing	_	VBG	_	_	1	PMOD	_	_
3	a	_	DT	_	_	4	NMOD	_	_
4	competitor	_	NN	_	_	2	OBJ	_	_
5	,	_	,	_	_	8	P	_	_
6	the	_	DT	_	_	7	NMOD	_	_
7	combination	_	NN	_	_	8	SBJ	_	_
8	should	_	MD	_	_	14	OBJ	_	_
9	provide	_	VB	_	_	8	VC	_	_
10	``	_	``	_	_	9	P	_	_
11	synergies	_	NNS	_	_	9	OBJ	_	_
12	,	_	,	_	_	14	P	_	_
13	''	_	''	_	_	14	P	_	_
14	said	_	VBD	_	_	0	ROOT	_	_
15	Fred	_	NNP	_	_	16	NAME	_	_
16	Harlow	_	NNP	_	_	14	SBJ	_	_
17	,	_	,	_	_	16	P	_	_
18	Unilab	_	NNP	_	_	22	NMOD	_	_
19	's	_	POS	_	_	18	SUFFIX	_	_
20	chief	_	NN	_	_	22	NMOD	_	_
21	financial	_	JJ	_	_	22	NMOD	_	_
22	officer	_	NN	_	_	16	APPO	_	_
23	.	_	.	_	_	14	P	_	_

1	It	_	PRP	_	_	3	SBJ	_	_
2	also	_	RB	_	_	3	ADV	_	_
3	will	_	MD	_	_	0	ROOT	_	_
4	hand	_	VB	_	_	3	VC	_	_
5	Unilab	_	NNP	_	_	4	OBJ	_	_
6	new	_	JJ	_	_	7	NMOD	_	_
7	markets	_	NNS	_	_	4	OBJ	_	_
8	.	_	.	_	_	3	P	_	_

1	In	_	IN	_	_	9	LOC	_	_
2	Los	_	NNP	_	_	3	NAME	_	_
3	Angeles	_	NNP	_	_	1	PMOD	_	_
4	,	_	,	_	_	9	P	_	_
5	for	_	IN	_	_	9	ADV	_	_
6	example	_	NN	_	_	5	PMOD	_	_
7	,	_	,	_	_	9	P	_	_
8	Central	_	NNP	_	_	9	SBJ	_	_
9	has	_	VBZ	_	_	0	ROOT	_	_
10	had	_	VBN	_	_	9	VC	_	_
11	a	_	DT	_	_	14	NMOD	_	_
12	strong	_	JJ	_	_	14	NMOD	_	_
13	market	_	NN	_	_	14	NMOD	_	_
14	position	_	NN	_	_	10	OBJ	_	_
15	while	_	IN	_	_	10	ADV	_	_
16	Unilab	_	NNP	_	_	18	NMOD	_	_
17	's	_	POS	_	_	16	SUFFIX	_	_
18	presence	_	NN	_	_	19	SBJ	_	_
19	has	_	VBZ	_	_	15	SUB	_	_
20	been	_	VBN	_	_	19	VC	_	_
21	less	_	RBR	_	_	22	AMOD	_	_
22	prominent	_	JJ	_	_	20	PRD	_	_
23	,	_	,	_	_	10	P	_	_
24	according	_	VBG	_	_	10	ADV	_	_
25	to	_	TO	_	_	24	PMOD	_	_
26	Mr.	_	NNP	_	_	27	TITLE	_	_
27	Harlow	_	NNP	_	_	25	PMOD	_	_
28	.	_	.	_	_	9	P	_	_

